PharmaLex furthers its scientific and regulatory attain


PharmaLex Group, a supplier of specialised providers for the pharma, biotech and medtech industries, has merged with expertise and providers group for scientific and regulatory options, Phlexglobal.

Phlexglobal affords its digital Trial Grasp File platform (PhlexTMF) and providers to a plethora of world life sciences firms and synthetic intelligence (AI)-enabled automation options that permit shoppers to learn from present scientific and regulatory coaching fashions.

“We’re delighted to welcome the Phlexglobal group to the PharmaLex Group, and the chance to proceed our dedication to innovation by additional increasing our technology-enabled service options portfolio with the addition of Phlexglobal’s capabilities for eTMF expertise and providers, in addition to their state-of-the-art regulatory operations and automation applied sciences,” says Dr. Thomas Dobmeyer, PharmaLex CEO. “The merger allows us to additional our aim of changing into a technology-enabled answer supplier, and on the identical time rising operational excellence and effectivity via our world material experience.”



Supply hyperlink